Joanna Coles, the former editor-in-chief of Cosmo (Cosmopolitan magazine) and the former chief content officer of Hearst, is our chairperson and CEO. In 2018, Queen Elizabeth recognized Ms. Coles for her contributions to journalism and the media industry by naming her an Officer of the Order of the British Empire, or OBE. (About Cosmo magazine: […]

We intend to focus on a target in an industry which complements our management team’s, board’s and sponsor’s expertise and which will benefit from our strategic and operational value add. Our management team is led by Ken Moelis, our Chairman, and Michael Spellacy, our Chief Executive Officer and a director. Mr. Moelis’ and Mr. Spellacy’s careers have […]

Mary Ann McGarry is the CEO of Guild Holdings. She is also the CEO of its flagship, Guild Mortgage Co., a position she has held since December 2007. She joined the company in 1984 as an internal audit supervisor. More from the prospectus: We are a growth-oriented mortgage company that employs a relationship-based loan sourcing strategy […]

We intend to focus our search on a target with operations or prospective operations in the technology, financial services, or media sectors, which we refer to as the “new economy sectors”, in Southeast Asia. Note: Peter Thiel, a co-founder of PayPal and the founder of Thiel Capital, is a backer of this newly organized blank […]

We intend to capitalize on the ability of our management team to identify promising opportunities in the biotechnology sector, with an emphasis on oncology and rare disease therapeutics where our management has extensive experience in investing, operating and drug development. Our founder and CEO is Luke Evnin of MPM Capital in Cambridge, Massachusetts. MPM Capital is […]

We intend to focus our search on telecommunications, media and technology (“TMT”) companies. Our management team, advisor and board of directors have had significant success sourcing, acquiring, expanding and monetizing these types of companies. We believe this experience makes us exceptionally well suited to identify, negotiate and successfully execute an initial business combination with the […]

(*Datto was priced at $27 – the top of its $24-to-$27 range – on 22 million shares on 10/20/20. Opened on 10/21/20 at $32, up 18.5 percent from its IPO price.) From the prospectus: Our mission is to create enterprise-grade technology for small and medium businesses delivered through our growing, global network of managed service […]

We intend to concentrate our efforts on identifying businesses in the financial services industry with a focus on delivering differentiated financial services in the wealth management, financial advisory and investment management sectors to the mass affluent and private client investor community.  Gary Wilder is our executive chairman. Michael Nessim is our CEO. Mr. Wilder is the group CEO […]

(Note: This is not an IPO, although the company says this is its IPO of American Depositary Shares (ADS) in the United States. From the prospectus: Each ADS represents represents eight ordinary shares. Our ordinary shares are listed on the Australian Securities Exchange under the symbol “OPT.” On Oct. 8, 2020, the last reported sale price […]

We are a late clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address large market opportunities initially in ophthalmic conditions where there are limited treatment alternatives. Our lead product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of […]